The Elusive Magic Bullet RSC Paperbacks
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Pre-Antibiotic Therapy of Syphilis Charles T
University of Kentucky UKnowledge Microbiology, Immunology, and Molecular Microbiology, Immunology, and Molecular Genetics Faculty Publications Genetics 2016 Pre-Antibiotic Therapy of Syphilis Charles T. Ambrose University of Kentucky, [email protected] Right click to open a feedback form in a new tab to let us know how this document benefits oy u. Follow this and additional works at: https://uknowledge.uky.edu/microbio_facpub Part of the Medical Immunology Commons Repository Citation Ambrose, Charles T., "Pre-Antibiotic Therapy of Syphilis" (2016). Microbiology, Immunology, and Molecular Genetics Faculty Publications. 83. https://uknowledge.uky.edu/microbio_facpub/83 This Article is brought to you for free and open access by the Microbiology, Immunology, and Molecular Genetics at UKnowledge. It has been accepted for inclusion in Microbiology, Immunology, and Molecular Genetics Faculty Publications by an authorized administrator of UKnowledge. For more information, please contact [email protected]. Pre-Antibiotic Therapy of Syphilis Notes/Citation Information Published in NESSA Journal of Infectious Diseases and Immunology, v. 1, issue 1, p. 1-20. © 2016 C.T. Ambrose This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. This article is available at UKnowledge: https://uknowledge.uky.edu/microbio_facpub/83 Journal of Infectious Diseases and Immunology Volume 1| Issue 1 Review Article Open Access PRE-ANTIBIOTICTHERAPY OF SYPHILIS C.T. Ambrose, M.D1* 1Department of Microbiology, College of Medicine, University of Kentucky *Corresponding author: C.T. Ambrose, M.D, College of Medicine, University of Kentucky Department of Microbiology, E-mail: [email protected] Citation: C.T. -
Arsinothricin, an Arsenic-Containing Non-Proteinogenic Amino Acid Analog of Glutamate, Is a Broad-Spectrum Antibiotic
ARTICLE https://doi.org/10.1038/s42003-019-0365-y OPEN Arsinothricin, an arsenic-containing non-proteinogenic amino acid analog of glutamate, is a broad-spectrum antibiotic Venkadesh Sarkarai Nadar1,7, Jian Chen1,7, Dharmendra S. Dheeman 1,6,7, Adriana Emilce Galván1,2, 1234567890():,; Kunie Yoshinaga-Sakurai1, Palani Kandavelu3, Banumathi Sankaran4, Masato Kuramata5, Satoru Ishikawa5, Barry P. Rosen1 & Masafumi Yoshinaga1 The emergence and spread of antimicrobial resistance highlights the urgent need for new antibiotics. Organoarsenicals have been used as antimicrobials since Paul Ehrlich’s salvarsan. Recently a soil bacterium was shown to produce the organoarsenical arsinothricin. We demonstrate that arsinothricin, a non-proteinogenic analog of glutamate that inhibits gluta- mine synthetase, is an effective broad-spectrum antibiotic against both Gram-positive and Gram-negative bacteria, suggesting that bacteria have evolved the ability to utilize the per- vasive environmental toxic metalloid arsenic to produce a potent antimicrobial. With every new antibiotic, resistance inevitably arises. The arsN1 gene, widely distributed in bacterial arsenic resistance (ars) operons, selectively confers resistance to arsinothricin by acetylation of the α-amino group. Crystal structures of ArsN1 N-acetyltransferase, with or without arsinothricin, shed light on the mechanism of its substrate selectivity. These findings have the potential for development of a new class of organoarsenical antimicrobials and ArsN1 inhibitors. 1 Department of Cellular Biology and Pharmacology, Florida International University, Herbert Wertheim College of Medicine, Miami, FL 33199, USA. 2 Planta Piloto de Procesos Industriales Microbiológicos (PROIMI-CONICET), Tucumán T4001MVB, Argentina. 3 SER-CAT and Department of Biochemistry and Molecular Biology, University of Georgia, Athens, GA 30602, USA. -
The Modern Drug Development - from Bench to Market
How are new drugs discovered and developed ? Discovery • Target identification, selection and validation • Target to Hit, Hit to Lead • Lead to Candidate (Lead Optimization) Development • Preclinical (safety, toxicology) • Clinical (Phase I, II, III) • Post-approval (Phase IV, post-market surveillance) 1 What is a drug ? Article intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease in humans or other animals; and articles (other than food) intended to affect the structure or any function of the body of humans or other animals. (FDA definition) Food and Drug Administration (FDA): a federal agency responsible for monitoring trading and safety standards in the food and drug industries. European Medicines Agency (EMA, EMEA): a European Union agency for the evaluation of medicinal products. Agenzia Italiana del Farmaco (AIFA). Once upon a time … Paul Ehrlich (1854–1915) 1890 German immunologist Paul Ehrlich (1854-1915) developed a chemical theory to explain the body’s immune response and did important work in chemotherapy, coining the term magic bullet. Ehrlich received the Nobel Prize in 1908. http://tibbs.unc.edu/magic-bullet-or-shot-in-the-dark/ The Side-chain theory and the magic bullet 3 From Immunology to The Magic Bullet Zauberkugel-Theorie’ A chemical substance can selectively affect physiological processes in the body. “A ‘magic bullet’ is a substance that can seek out and kill the disease causing agents only”. 4 The Movie 1940 5 Salvarsan (Hoechst) the first chemotherapy Arsphenamine (Salvarsan or compound 606) is a drug introduced at the beginning of the 1910s as the first effective treatment for syphilis, and was also used to treat trypanosomiasis. -
Drugs That Changed the World
Drugs That Changed the World Drugs That Changed the World How Therapeutic Agents Shaped Our Lives Irwin W. Sherman CRC Press Taylor & Francis Group 6000 Broken Sound Parkway NW, Suite 300 Boca Raton, FL 33487-2742 © 2017 by Taylor & Francis Group, LLC CRC Press is an imprint of Taylor & Francis Group, an Informa business No claim to original U.S. Government works Printed on acid-free paper Version Date: 20160922 International Standard Book Number-13: 978-1-4987-9649-1 (Hardback) This book contains information obtained from authentic and highly regarded sources. While all reasonable efforts have been made to publish reliable data and information, neither the author[s] nor the publisher can accept any legal respon- sibility or liability for any errors or omissions that may be made. The publishers wish to make clear that any views or opinions expressed in this book by individual editors, authors or contributors are personal to them and do not neces- sarily reflect the views/opinions of the publishers. The information or guidance contained in this book is intended for use by medical, scientific or health-care professionals and is provided strictly as a supplement to the medical or other professional’s own judgement, their knowledge of the patient’s medical history, relevant manufacturer’s instructions and the appropriate best practice guidelines. Because of the rapid advances in medical science, any information or advice on dosages, procedures or diagnoses should be independently verified. The reader is strongly urged to consult the relevant national drug formulary and the drug companies’ and device or material manufacturers’ printed instructions, and their websites, before administering or utilizing any of the drugs, devices or materials mentioned in this book. -
Microbe Hunters Revisited Yale University School of Medicine, New Haven, Connecticut, USA
INTERNATL MICROBIOL (1998) 1: 65-68 65 © Springer-Verlag Ibérica 1998 PERSPECTIVES William C. Summers Microbe Hunters revisited Yale University School of Medicine, New Haven, Connecticut, USA Correspondence to: William C. Summers. Yale University School of Medicine. 333 Cedar St. New Haven, CT 06520-8040. USA. Tel.: +1-203-785 2986. Fax: +1-203-785 6309. E-mail: [email protected] It was the mid-1950s and I was a teenager when I first Indeed, Microbe Hunters is a book about success: tales of read Microbe Hunters by Paul Henry De Kruif (Zealand, MI, brilliant research, incisive investigations, and heroic 1890–Holland, MI, 1971). It was the right time and the right personalities. Yet it is far from “history-objectively written.” age; I was fascinated. Here were heros enough to satisfy any The formula that De Kruif hit upon in Microbe Hunters served bookish young man interested in the natural world. Microbe him well: between 1928 and 1957 he wrote eleven more books Hunters was a book that inspired a generation or more of on medical and scientific topics, all with the same “exciting budding young microbiologists [4]. Not only that, however. narrative” and sense of drama. Some of these books were best- It established a metaphor and a genre of science writing that sellers and selected by the popular Book-of-the-Month Club. has often been imitated. None, however, matched the popularity and appeal of Microbe Microbe Hunters is a series of 12 stories that describe major Hunters. events in the history of microbiology, from microscopic De Kruif’s stories are full-scale dramatizations, complete observations of animalcules (literally “little animals”) by with fictional dialog of the historical subjects, and first person Leeuwenhoek (“First of the Microbe Hunters”) to Paul Ehrlich’s interjections of the voice of the narrator, De Kruif. -
Of Rabbits and Men: the Tale of Paul Ehrlich in Our Modern World Of
Of Rabbits and Men: The Tale of Paul Ehrlich In our modern world of chemotherapy, antibiotics and antivirals, it might come as a surprise to find that the origin of all these treatments can be traced back to rabbits; the cute and fluffy kind. To understand why, we need to go all the way back to 1882 Berlin. A talented, if aimless, young German doctor, Paul Ehrlich, had just met the great microbiologist Robert Koch. Koch was giving a lecture in which he identified the pathogen responsible for tuberculosis. Ehrlich was instantly fascinated by Koch and microbiology. Unknown to himself, he had just taken the first step on a path that would help change the way disease is tackled forever1. The late 1800’s were a time of dynamic change in the sciences. Charles Darwin had proposed his Theory of Natural Selection and Thomas Edison had given us the light bulb. Amongst the many fashionable topics of the time, some biologists were fascinated by dyes; specifically the staining of living tissue. Spending all day bent over a microscope looking at the pretty colours might not seem like worthwhile science by modern standards, but these dyes had interesting properties. Dyes displayed a high level of specificity; they would only stain certain structures and pass through others. Ehrlich noticed this and soon started to think of applications for these properties. These were times when catching a chill could kill. Many well-known individuals of the time were killed in their prime due to infectious disease. Emily Brontë died from tuberculosis2, René Descartes from pneumonia3 and Pyotr Tchaikovsky died from cholera4. -
UNIVERSITY of CALIFORNIA the Role of United States Public Health Service in the Control of Syphilis During the Early 20Th Centu
UNIVERSITY OF CALIFORNIA Los Angeles The Role of United States Public Health Service in the Control of Syphilis during the Early 20th Century A dissertation submitted in partial satisfaction of the requirements for the degree of Doctor of Public Health by George Sarka 2013 ABSTRACT OF THE DISSERTATION The Role of United States Public Health Service in the Control of Syphilis during the Early 20th Century by George Sarka Doctor of Public Health University of California, Los Angeles, 2013 Professor Paul Torrens, Chair Statement of the Problem: To historians, the word syphilis usually evokes images of a bygone era where lapses in moral turpitude led to venereal disease and its eventual sequelae of medical and moral stigmata. It is considered by many, a disease of the past and simply another point of interest in the timeline of medical, military or public health history. However, the relationship of syphilis to the United States Public Health Service is more than just a fleeting moment in time. In fact, the control of syphilis in the United States during the early 20th century remains relatively unknown to most individuals including historians, medical professionals and public health specialists. This dissertation will explore following question: What was the role of the United States Public Health Service in the control of syphilis during the first half of the 20th century? This era was a fertile period to study the control of syphilis due to a plethora of factors including the following: epidemic proportions in the U.S. population and military with syphilis; the ii emergence of tools to define, recognize and treat syphilis; the occurrence of two world wars with a rise in the incidence and prevalence of syphilis, the economic ramifications of the disease; and the emergence of the U.S. -
Syphilis - Its Early History and Treatment Until Penicillin, and the Debate on Its Origins
History Syphilis - Its Early History and Treatment Until Penicillin, and the Debate on its Origins John Frith, RFD Introduction well as other factors such as education, prophylaxis, training of health personnel and adequate and rapid “If I were asked which is the most access to treatment. destructive of all diseases I should unhesitatingly reply, it is that which Up until the early 20th century it was believed that for some years has been raging with syphilis had been brought from America and the New impunity ... What contagion does World to the Old World by Christopher Columbus in thus invade the whole body, so much 1493. In 1934 a new hypothesis was put forward, resist medical art, becomes inoculated that syphilis had previously existed in the Old World so readily, and so cruelly tortures the before Columbus. I In the 1980’s palaeopathological patient ?” Desiderius Erasmus, 1520.1 studies found possible evidence that supported this hypothesis and that syphilis was an old treponeal In 1495 an epidemic of a new and terrible disease broke disease which in the late 15th century had suddenly out among the soldiers of Charles VIII of France when evolved to become different and more virulent. Some he invaded Naples in the first of the Italian Wars, and recent studies however have indicated that this is not its subsequent impact on the peoples of Europe was the case and it still may be a new epidemic venereal devastating – this was syphilis, or grande verole, the disease introduced by Columbus from America. “great pox”. Although it didn’t have the horrendous mortality of the bubonic plague, its symptoms were The first epidemic of the ‘Disease of Naples’ or the painful and repulsive – the appearance of genital ‘French disease’ in Naples 1495 sores, followed by foul abscesses and ulcers over the rest of the body and severe pains. -
The Impact of Polypharmacology on Chemical Biology
The impact of polypharmacology on chemical biology Albert Antolín Hernández TESI DOCTORAL UPF / ANY 2014 DIRECTOR DE LA TESI: Dr. Jordi Mestres CEXS Department The research in this Thesis has been carried out at the Systems Pharmacology Research Group, within the Research Programme on Biomedical Informatics (GRIB) at Parc de Recerca Biomèdica de Barcelona (PRBB). The research presented in this Thesis has been supported by Ministerio de Ciencia e Innovación Project BIO2005-041171, BIO2008-02329, BIO2011- 26669 and PTA2009-1865P and the Catalan Government grant 2013FIB2- 00073. Printing funded by the Fundació IMIM’s program “Convocatòria d'ajuts 2014 per a la finalització de tesis doctorals de la Fundació IMIM.” A en Juan, Per ensenyar-me que la realitat també pot ser màgica. Agraïments Una tesi és molt més que un escrit final. Son les persones, les experiències i les vivències que m’han acompanyat durant tots aquests anys. És per això que en les següents ratlles voldria agrair-vos a tots aquells que heu format part i heu fet possible aquesta aventura! En primer lloc, voldria donar les gràcies al meu director de tesi, el Dr. Jordi Mestres. Gràcies per confiar en mi, per ajudar-me amb el finançament abans que em donessin la beca i per permetre’m formar part del Laboratori i aplicar el software que durant anys heu anat desenvolupant. Ha estat una oportunitat increïble! També pels moments més difícils, per la canya i els reptes amb que he anat creixent, per tot l’esforç depositat en aquesta tesi i per les interessants converses finals sobre -
Magic Bullet” Is Here? Cell-Based Immunotherapies for Hematological Malignancies in the Twilight of the Chemotherapy Era
cells Review The “Magic Bullet” Is Here? Cell-Based Immunotherapies for Hematological Malignancies in the Twilight of the Chemotherapy Era Nina Miazek-Zapala 1,2, Aleksander Slusarczyk 1,3 , Aleksandra Kusowska 1, Piotr Zapala 3, Matylda Kubacz 1, Magdalena Winiarska 1 and Malgorzata Bobrowicz 1,* 1 Department of Immunology, Medical University of Warsaw, 02-097 Warsaw, Poland; [email protected] (N.M.-Z.); [email protected] (A.S.); [email protected] (A.K.); [email protected] (M.K.); [email protected] (M.W.) 2 Institute of Physiology and Pathophysiology of Hearing, World Hearing Center, 05-830 Nadarzyn, Poland 3 Department of General, Oncological and Functional Urology, Medical University of Warsaw, 02-005 Warsaw, Poland; [email protected] * Correspondence: [email protected] Abstract: Despite the introduction of a plethora of different anti-neoplastic approaches including standard chemotherapy, molecularly targeted small-molecule inhibitors, monoclonal antibodies, and finally hematopoietic stem cell transplantation (HSCT), there is still a need for novel therapeutic options with the potential to cure hematological malignancies. Although nowadays HSCT already offers a curative effect, its implementation is largely limited by the age and frailty of the patient. Moreover, its efficacy in combating the malignancy with graft-versus-tumor effect frequently coexists with undesirable graft-versus-host disease (GvHD). Therefore, it seems that cell-based adoptive Citation: Miazek-Zapala, N.; immunotherapies may constitute optimal strategies to be successfully incorporated into the standard Slusarczyk, A.; Kusowska, A.; Zapala, P.; Kubacz, M.; Winiarska, M.; therapeutic protocols. Thus, modern cell-based immunotherapy may finally represent the long- Bobrowicz, M. -
2-Microbe-Hunters-Paul-De-Kruif.Pdf
Microbe Hunters Paul de Kruif To RHEA A Harvest/HBJ Book Harcourt Brace Jovanovich, Publishers San Diego New York London Copyright 1926 by Paul de Kruif Copyright renewed 1954 by Paul de Kruif All rights reserved. No part of this publication may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopy, recording, or any information storage and retrieval system, without permission in writing from the publisher. Table of Contents 1. LEEUWENHOEK: First of the Microbe Hunters 2. SPALLANZANI: Microbes Must Have Parents! 3. PASTEUR: Microbes Are a Menace! 4. KOCH: The Death Fighter 5. PASTEUR: And the Mad Dog 6. ROUX AND BEHRING: Massacre the Guinea-Pigs 7. METCHNIKOFF: The Nice Phagocytes 8. THEOBALD SMITH: Ticks and Texas Fever 9. BRUCE: Trail of the Tsetse 10. ROSS VS. GRASSI: Malaria 11. WALTER REED: In the Interest of Science-and for Humanity! 12. PAUL EHRLICH: The Magic Bullet Footnotes Books by Paul de Kruif 1. LEEUWENHOEK: First of the Microbe Hunters 1 Two hundred and fifty years ago an obscure man named Leeuwenhoek looked for the first time into a mysterious new world peopled with a thousand different kinds of tiny beings, some ferocious and deadly, others friendly and useful, many of them more important to mankind than any continent or archipelago. Leeuwenhoek, unsung and scarce remembered, is now almost as unknown as his strange little animals and plants were at the time he discovered them. This is the story of Leeuwenhoek, the first of the microbe hunters. It is the tale of the bold and persistent and curious explorers and fighters of death who came after him. -
Might Become 'A Framework for Study
DOCUMENT RESUME ED 028 940 SE 006 545 By-Busch. PhyNis S. Venereal Disease. A Teaching Reference Guide. New Jersey State Dept. of Education, Trenton.; New Jersey State Dept. of Health. Trenton. Pub Date 64 Note-90p. EDRS Price Mr-S0.50 HC-S4.60 Descriptors-AudiovisualAids,Bibliographies, Disease Control,*Diseases, *Health Education, Resource Materials, *Secondary School Science, *Teaching Guides, Youth Problems This guide developed for use in the secondary schools of New Jersey makes suggestions for venereal disease education which have been tested in a wide variety of classroorti situations. The document focuses on the kinds of questions for which young people are seeking answers. An attempt is made to illustrate problems which might become 'a framework for study. Many suggestions are made for motivating students and teaching the topic. Appendixed is teacher background information which indudes article reprints, research data, a film list, and a wide variety of references. (DS) U.S. DEPARTMENT OF HEALTH, EDUCATION & WELFARE OFFICE OF EDUCATION THIS DOCUMENT HAS BEEN REPRODUCED EXACTLYAS RECEIVED, FROM THE PERSON OR ORGANIZATION ORIGINATING IT.POINTS OF VIEW OR OPINIONS STATED DO NOT NECESSARILY REPRESENT OFFICIALOFFICE OF EDUCATION POSITION OR POLICY. ateaching reference guitk VENEREAL DISEASE DIVISION OF CURRICULUM AND INSTRUCTION DEPARTMENT OF EDUCATION STATE OF NEW JERSEY is cporstin with NEW JERSEY STATE DEPARTMENT OF HEALTH 1 Venereal Disease A TEACHING REFERENCE GUIDE Compiled by Phyllis S. Busch, Consultant Division of Curriculum and Instruction Department of Education State of New Jersey in cooperation with the New Jersey State of Department of Health TABLE OF CONTENTS PAGE A Letter from the Commissioner Foreword by Robert S.